Continuing Interprofessional Education (CIPE)

Workshop Series 

Multidisciplinary Perspectives on the Science

and Practice of Psychedelic Therapies.

TAKE ONE TRAINING OR TAKE THEM ALL

As research into the efficacy of psychedelic-assisted therapies (PAT) to treat various mental health conditions expands, it becomes increasingly vital for the healthcare workforce to be knowledgeable about the science, clinical practices and regulatory aspects of this emerging field. This workshop series addresses the urgent need for trained healthcare professionals who understand the latest clinical research evidence on the benefits and potential risks of PAT, ethical considerations in the delivery of harm reduction and PAT clinical practices, and the rapidly changing policy, legal, and insurance landscapes that affect health care providers and the delivery of PAT services.

Workshop Overview

This Continuing Interprofessional Education series equips participants with foundational knowledge in the history and psychopharmacology of psychedelics; the state of clinical research findings about the efficacy and risks of Psychedelic-Assisted Therapy (PAT) for different psychedelic compounds and specific mental health conditions; access, social justice, and diversity issues related to the delivery of psychedelic therapies; harm reduction methods for integrating this knowledge into existing clinical practices; and the legal landscape for healthcare providers.

Target Audience:

This workshop series is designed for health professionals interested in expanding their knowledge and competencies in psychedelic science and therapeutic practices:

Nurses

Pharmacists

Social Workers

Licensed Clinical Professional Counselors

Psychologists

Medical Doctors

Series Learning objectives:

1. Clinical Research Evidence: Participants will gain foundational knowledge about the current state of research findings with Psychedelic-Assisted Therapies (PAT) using Ketamine, MDMA and Psilocybin and the implications for the future of addiction, trauma, depression, and pain and palliative care treatments.

2. Regulatory Landscape: Participants will gain a comprehensive overview of the current U.S. and global regulations surrounding psychedelics and understand the implications of evolving psychedelic laws for healthcare settings and equitable access to PAT services.

3. Harm Reduction Strategies: Attendees will explore best practices and ethical considerations essential for practitioners operating within the psychedelic ecosystem, focusing on minimizing risks while maximizing therapeutic benefits.

4. Equitable Access and Cultural Humility: The series will examine the history and indigenous use of psychedelic compounds, key social justice and mental health care access challenges with the medicalization and scaling of PAT services, and the roles and responsibilities of the health professions in addressing these challenges from a stance of cultural humility to ensure inclusive care that respects diverse backgrounds and identities.

5. Practical Applications: Through discussions and group exercises, participants will learn how to apply insights learned from workshop presenters to their clinical practices and healthcare settings.

TAKE ONE TRAINING OR TAKE THEM ALL

ACTIVITY ANNOUNCEMENT FOR PHARMACISTS: 

https://ce.pharmacy.umaryland.edu/uploads/Psychedelics_Workshop_Series_Activity_Announcement.pdf

Nurses: 

The University of Maryland School of Nursing is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Nurses may receive 3.0 contact hours for attending this entire training activity and completing the evaluation.